Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
Más filtros

Base de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
World J Clin Cases ; 10(10): 3027-3034, 2022 Apr 06.
Artículo en Inglés | MEDLINE | ID: mdl-35647114

RESUMEN

BACKGROUND: The incidence of thyroid cancer is increasing annually. Clinical routine thyroid surgery can be performed under a cervical plexus block, but cannot mediate the stress response during the surgery. If thyroid surgery is performed under nerve block, an inappropriate level of blockade may occur. Similarly, the stress response caused by surgery is more serious than that caused by conventional anesthesia. Therefore, it is important to combine blockade with more effective anesthesia methods. AIM: To investigate the effects of combining sevoflurane-dexmedetomidine inhalation general anesthesia with the cervical plexus nerve block on the post-surgical levels of the serum oxidative stress biomarkers levels in thyroid cancer patients. METHODS: We enrolled 96 thyroid cancer patients admitted to the hospital between January 2019 and December 2020. Participants were divided into a control group (n = 47) and an experimental group (n = 49). The experimental group received a combination of inhaled sevoflurane-dexmedetomidine and cervical plexus block, while the control group received conventional general anesthesia. The groups were compared for serum levels of monocyte chemotactic protein-1 (MCP-1) and glutathione peroxidase (GSH-Px) before and after surgery, and the adrenocorticotropic hormone (ACTH) and norepinephrine (NE) levels at 1 and 12 h post-surgery. The Bispectral index (BIS) and the incidence of anesthesia side effects were also compared. RESULTS: Following surgery, MCP-1 was significantly lower in the experimental group compared to the control group, whereas GSH-Px was significantly higher than that in the control group (P < 0.001). The serum ACTH and NE levels were significantly lower in the experimental group than those the control group at 1 and 12 h post-surgery (P < 0.001). BIS was significantly lower in the experimental group than that in the control group at 20 minutes into the operation, but the direction of the difference was reversed at eye opening (P < 0.001). The incidence of side effects was 10.20% (5/49) and 12.76% (6/47) in the experimental and control groups, respectively, the difference being non-significant. CONCLUSION: Sevoflurane-dexmedetomidine inhalation general anesthesia combined with cervical plexus nerve block can reduce the postoperative stress and inflammatory responses in thyroid cancer patients, while maintaining high anesthesia effectiveness and safety.

2.
EClinicalMedicine ; 25: 100463, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32838236

RESUMEN

BACKGROUND: The long-term pulmonary function and related physiological characteristics of COVID-19 survivors have not been studied in depth, thus many aspects are not understood. METHODS: COVID-19 survivors were recruited for high resolution computed tomography (HRCT) of the thorax, lung function and serum levels of SARS-CoV-2 IgG antibody tests 3 months after discharge. The relationship between the clinical characteristics and the pulmonary function or CT scores were investigated. FINDINGS: Fifty-five recovered patients participated in this study. SARS-CoV-2 infection related symptoms were detected in 35 of them and different degrees of radiological abnormalities were detected in 39 patients. Urea nitrogen concentration at admission was associated with the presence of CT abnormalities (P = 0.046, OR 7.149, 95% CI 1.038 to 49.216). Lung function abnormalities were detected in 14 patients and the measurement of D-dimer levels at admission may be useful for prediction of impaired diffusion defect (P = 0.031, OR 1.066, 95% CI 1.006 to 1.129). Of all the subjects, 47 of 55 patients tested positive for SARS-CoV-2 IgG in serum, among which the generation of Immunoglobulin G (IgG) antibody in female patients was stronger than male patients in infection rehabilitation phase. INTERPRETATION: Radiological and physiological abnormalities were still found in a considerable proportion of COVID-19 survivors without critical cases 3 months after discharge. Higher level of D-dimer on admission could effectively predict impaired DLCO after 3 months discharge. It is necessary to follow up the COVID-19 patients to appropriately manage any persistent or emerging long-term sequelae. FUNDING: Key Scientific Research Projects of Henan Higher Education Institutions.

3.
Sleep Med ; 72: 5-11, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32534403

RESUMEN

BACKGROUND: The goal of this study was to review relevant randomized controlled trials in order to determine the efficacy of continuous positive airway pressure (CPAP) versus mandibular advancement device (MAD) in the treatment of obstructive sleep apnea (OSA). METHODS: Using appropriate keywords, we identified relevant studies using PubMed, the Cochrane Library, and Embase. Key pertinent sources in the literature were also reviewed, and all articles published through October 2019 were considered for inclusion. For each study, we used odds ratios (ORs), mean difference (MD), and 95% confidence interval (95% CI) to assess and synthesize outcomes. RESULTS: We included 14 RCTs, for a total of 249 patients in the CPAP group and 247 in the MAD group. Compared with MAD, CPAP significantly decreased apnea hypopnea index (AHI) (WMD: -7.08, 95%CI: -9.06∼-5.10) and the percentage of stage 1 and 2 after therapy (WMD: -3.728, 95%CI: -6.912∼-0.543). However, compared with MAD, CPAP significantly decreased the SF-36-social function score (WMD: -3.381, 95%CI: -6.607∼-0.154).There was no significant difference in Epworth sleepiness scale score after therapy between the two groups. CONCLUSION: CPAP has better therapeutic efficacy in OSA patients than MAD.


Asunto(s)
Avance Mandibular , Apnea Obstructiva del Sueño , Presión de las Vías Aéreas Positiva Contínua , Humanos , Ferulas Oclusales , Ensayos Clínicos Controlados Aleatorios como Asunto , Apnea Obstructiva del Sueño/terapia
4.
Cancer Immunol Immunother ; 69(8): 1493-1504, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32285170

RESUMEN

Though therapy that promotes anti-tumor response about CD8+ tumor-infiltrating lymphocytes (TILs) has shown great potential, clinical responses to CD8+ TILs immunotherapy vary considerably, largely because of different subpopulation of CD8+ TILs exhibiting different biological characters. To define the relationship between subpopulation of CD8+ TILs and the outcome of antitumor reaction, the phenotype and function of CD103+ CD8+ TILs in esophageal squamous cell carcinoma (ESCC) were investigated. CD103+ CD8+ TILs were presented in ESCC, which displayed phenotype of tissue-resident memory T cells and exhibited high expression of immune checkpoints (PD-1, TIM-3). CD103+ CD8+ TILs were positively associated with the overall survivals of ESCC patients. This population of cells elicited potent proliferation and cytotoxic cytokine secretion potential. In addition, CD103+ CD8+ TILs were elicited potent anti-tumor immunity after anti-PD-1 blockade and were not affected by chemotherapy. This study emphasized the feature of CD103+ CD8+ TILs in immune response and identified potentially new targets in ESCC patients.


Asunto(s)
Antígenos CD/metabolismo , Linfocitos T CD8-positivos/inmunología , Neoplasias Esofágicas/inmunología , Neoplasias Esofágicas/metabolismo , Cadenas alfa de Integrinas/metabolismo , Linfocitos Infiltrantes de Tumor/inmunología , Receptor de Muerte Celular Programada 1/antagonistas & inhibidores , Microambiente Tumoral/inmunología , 4-Nitroquinolina-1-Óxido/toxicidad , Adulto , Anciano , Animales , Anticuerpos Monoclonales/farmacología , Antígenos CD/inmunología , Biomarcadores de Tumor , Carcinógenos/toxicidad , Estudios de Cohortes , Neoplasias Esofágicas/inducido químicamente , Neoplasias Esofágicas/patología , Carcinoma de Células Escamosas de Esófago/inducido químicamente , Carcinoma de Células Escamosas de Esófago/inmunología , Carcinoma de Células Escamosas de Esófago/metabolismo , Carcinoma de Células Escamosas de Esófago/patología , Femenino , Estudios de Seguimiento , Humanos , Cadenas alfa de Integrinas/inmunología , Masculino , Ratones Endogámicos C57BL , Persona de Mediana Edad , Pronóstico , Receptor de Muerte Celular Programada 1/inmunología , Tasa de Supervivencia , Células Tumorales Cultivadas
5.
Heart Lung ; 48(6): 515-518, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31146967

RESUMEN

OBJECTIVE: The purpose of this study was to assess the fibrinolytic status after cardiopulmonary bypass in rheumatic valvular heart disease patients, and detect the associated factors of post-cardiopulmonary bypass hyperfibrinolysis. METHODS: According to the fibrinolytic status after cardiopulmonary bypass, 203 rheumatic valvular heart disease patients were divided into two groups: hyperfibrinolysis group (H group, n = 78) and non-hyperfibrinolysis group (NH group, n = 125). The demographic characteristics, operative variables, and postoperative follow-ups were compared between these two groups. RESULTS: The incidence of hyperfibrinolysis was 38.4% after cardiopulmonary bypass. Patients in the H group had a significant higher incidence of preoperative atrial fibrillation than patients in the NH group (92.3% vs. 55.2%, P < 0.01). Furthermore, postoperative daily drainage (655.3 ±â€¯131.5 ml vs. 535.4 ±â€¯161.4 ml, P < 0.01), transfusion volume of fresh frozen plasma (621.8 ±â€¯220.2 ml vs. 455.2 ±â€¯208.5 ml, P < 0.01), and red blood cells (5.9 ±â€¯2.2 u vs. 4.7 ±â€¯2.8 u, P < 0.01) was greater in the H group than in the NH group. Moreover, the logistic regression analysis revealed that preoperative atrial fibrillation was associated with post-cardiopulmonary bypass hyperfibrinolysis (OR = 19.691, 95% CI = 6.849-56.612; P < 0.05). CONCLUSION: Preoperative artial fibrillation is associated with post-cardiopulmonary bypass hyperfibrinolysis in rheumatic valvular heart disease patients.


Asunto(s)
Fibrilación Atrial/diagnóstico , Puente Cardiopulmonar/métodos , Enfermedades de las Válvulas Cardíacas/cirugía , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
6.
Front Immunol ; 9: 2821, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30555485

RESUMEN

TIGIT, an immune checkpoint molecule widely expressed on NK cells, activated T cells and Tregs, has been involved in delivering inhibitory signals through the interaction with PVR. The blockade of TIGIT/PVR interaction is a promising approach in cancer immunotherapy. Here, we unexpectedly discovered the expression of TIGIT in murine tumor cells. To elucidate the mechanism of such intrinsic expression, TIGIT knockout murine colorectal CT26 and MC38 cell lines were generated by using CRISPR/Cas9 system. Although TIGIT knockout showed no effects on proliferation and colony formation of tumor cells in vitro, the tumor growth in mice was considerably inhibited. TIGIT knockout led to the increase of IFN-γ secretion by NK and CD8+ T cells. Further, in BABL/c nude mice, CD8+ T cells depleting mice and NK cells depleting nude mice, the promotion of tumor growth was significantly diminished, suggesting that both NK cells and CD8+ T cells were involved in the tumor promoting process mediated by intrinsic TIGIT. In addition, blocking TIGIT/PVR interaction by the antibody or recombinant PVR protein could elicit anti-tumor effects by facilitating the tumor infiltration and restoring the function of CD8+ T cells, and the antibody-mediate TIGIT blockade could inhibit MC38 tumor growth through blocking TIGIT expressed on tumor cells. We therefore propose a novel TIGIT/PVR interaction mode that tumor intrinsic TIGIT delivers inhibitory signals to CD8+ T cells and NK cells by engaging with PVR.


Asunto(s)
Linfocitos T CD8-positivos/inmunología , Neoplasias Colorrectales/inmunología , Células Asesinas Naturales/inmunología , Proteínas de Neoplasias/inmunología , Receptores Inmunológicos/inmunología , Transducción de Señal/inmunología , Animales , Linfocitos T CD8-positivos/patología , Neoplasias Colorrectales/genética , Neoplasias Colorrectales/patología , Femenino , Técnicas de Inactivación de Genes , Xenoinjertos , Humanos , Células Asesinas Naturales/patología , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Desnudos , Proteínas de Neoplasias/genética , Trasplante de Neoplasias , Receptores Inmunológicos/genética , Transducción de Señal/genética
7.
Biochem Biophys Res Commun ; 504(4): 820-826, 2018 10 12.
Artículo en Inglés | MEDLINE | ID: mdl-30219228

RESUMEN

This study aimed to elucidate the effect of miR-1306-3p on metastasis of hepatocellular carcinoma (HCC) and potential mechanism involved. miR-1306-3p promoted migration and invasion of HCC in vivo and in vitro. Moreover, miR-1306-3p inhibited snail to enhance its expression via directly targeting FBXL5, thus inducing the epithelial-mesenchymal transition (EMT) in HCC. Intriguingly, miR-1306-3p expression was transcriptionally enhanced by FoxM1. Consistently, miR-1306-3p was upregulated in HCC compared with paracarcinoma and correlated with poor prognosis of HCC patients. Our researches suggest that miR-1306-3p is a tumor enhancer in regulating of HCC metastasis, and miR-1306-3p may be clinically utilized as a factor for the clinical diagnosis and prognosis of HCC.


Asunto(s)
Carcinoma Hepatocelular/patología , Proteínas F-Box/genética , Neoplasias Hepáticas/patología , MicroARNs/metabolismo , Factores de Transcripción de la Familia Snail/metabolismo , Complejos de Ubiquitina-Proteína Ligasa/genética , Animales , Biomarcadores de Tumor/genética , Carcinoma Hepatocelular/genética , Carcinoma Hepatocelular/metabolismo , Carcinoma Hepatocelular/mortalidad , Línea Celular Tumoral , Transición Epitelial-Mesenquimal/genética , Proteínas F-Box/metabolismo , Proteína Forkhead Box M1/genética , Proteína Forkhead Box M1/metabolismo , Regulación Neoplásica de la Expresión Génica , Humanos , Neoplasias Hepáticas/genética , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/mortalidad , Masculino , Ratones Endogámicos BALB C , MicroARNs/genética , Oncogenes , Pronóstico , Proteolisis , Factores de Transcripción de la Familia Snail/genética , Complejos de Ubiquitina-Proteína Ligasa/metabolismo , Ensayos Antitumor por Modelo de Xenoinjerto
8.
Medicine (Baltimore) ; 97(28): e10908, 2018 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-29995750

RESUMEN

Since there were a few articles to report the treatment of severe pulmonary vasoconstriction induced by protamine in cardiac surgery, we described the use of epoprostenol to reverse this condition.A total of 5 cases of severe pulmonary vasoconstriction induced by protamine in cardiac surgery were reviewed. The demographic, clinical data and treatment process were obtained. All the patients were followed up.Severe pulmonary vasoconstriction was occurred 4 to 10 minutes after protamine infusion. The primary sign was sudden hypotension, the pulmonary artery pressure was increased gradually, the arterial oxygen partial pressure was decreased in all the patients. Epoprostenol was infused via pulmonary artery catheter at dosage of 20 to 40 ng/kg·min in all the patients, 2 patients were underwent re-cardiac pulmonary bypass assistance. The hemodynamic instability status lasted 40 to 65 minutes respectively. All the patients were recovered uneventfully.All physicians should alert to the incidence of severe pulmonary vasoconstriction induced by protamine in cardiac surgery. Use epoprostenol through pulmonary artery catheter could treat pulmonary artery vasoconstriction effectively and safely.


Asunto(s)
Procedimientos Quirúrgicos Cardíacos/métodos , Epoprostenol/administración & dosificación , Hemodinámica/efectos de los fármacos , Hipertensión Pulmonar , Complicaciones Intraoperatorias , Protaminas/efectos adversos , Adulto , Anciano , Antihipertensivos/administración & dosificación , China , Monitoreo de Drogas/métodos , Femenino , Antagonistas de Heparina/administración & dosificación , Antagonistas de Heparina/efectos adversos , Humanos , Hipertensión Pulmonar/inducido químicamente , Hipertensión Pulmonar/diagnóstico , Hipertensión Pulmonar/tratamiento farmacológico , Complicaciones Intraoperatorias/inducido químicamente , Complicaciones Intraoperatorias/diagnóstico , Complicaciones Intraoperatorias/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Monitoreo Intraoperatorio/métodos , Protaminas/administración & dosificación , Estudios Retrospectivos , Resultado del Tratamiento , Vasoconstricción/efectos de los fármacos
9.
Respir Care ; 63(8): 988-993, 2018 08.
Artículo en Inglés | MEDLINE | ID: mdl-29844213

RESUMEN

BACKGROUND: The balance of oxygen delivery and consumption is essential in patients who are critically ill. Mixed venous oxygen saturation (Sv̄O2 ) is a standard method to evaluate oxygen delivery and consumption during anesthesia. However, Sv̄O2 is monitored through a pulmonary artery catheter, which is invasive. Regional cerebral oxygenation (rScO2) reflects oxygen saturation in a small region of the frontal lobes and is monitored noninvasively through near-infrared spectroscopy. In the present study, the correlation between rScO2 and Sv̄O2 was calculated during off-pump coronary artery bypass grafting surgery to determine whether a positive correlation exists between rScO2 and Sv̄O2 . METHODS: A total of 56 subjects were consecutively enrolled in the study. Then rScO2 and Sv̄O2 were simultaneously monitored. The parameters were recorded at 5 time points: T1, 10 min after intubation (1.0 FIO2 for 10 min); T2, 20 min after intubation (0.60 FIO2 for 10 min); T3, at the end of the revascularization of the left anterior descending artery (0.60 FIO2 ); T4, after protamine infusion (0.60 FIO2 ); and T5, 10 min after protamine infusion (1.0 FIO2 for 10 min). The correlation between rScO2 and Sv̄O2 and the variation trend between rScO2 and Sv̄O2 when FIO2 increased from 0.60 to 1.0 were analyzed. RESULTS: There was a significant positive correlation between rScO2 and Sv̄O2 at these 5 time points (r 2 = 0.77, 0.81, 0.70, 0.83, and 0.92, respectively). There also was a significant positive correlation between Δ rScO2 and Δ Sv̄O2 (n = 112, r 2 = 0.72, P < .001). Linear regression analysis revealed that Sv̄O2 had a positive correlation with rScO2 and cardiac output (r 2 = 0.68, P = .013). CONCLUSIONS: There was a positive correlation between rScO2 and Sv̄O2 during off-pump coronary artery bypass grafting surgery, and there also was a positive correlation in the variation trend between rScO2 and Sv̄O2 .


Asunto(s)
Puente de Arteria Coronaria Off-Pump , Lóbulo Frontal/metabolismo , Oxígeno/sangre , Espectroscopía Infrarroja Corta , Anciano , Análisis de los Gases de la Sangre , Gasto Cardíaco , Femenino , Humanos , Venas Yugulares , Masculino , Persona de Mediana Edad , Monitoreo Intraoperatorio , Oxígeno/administración & dosificación , Consumo de Oxígeno , Estudios Prospectivos
10.
Nat Commun ; 7: 12598, 2016 08 24.
Artículo en Inglés | MEDLINE | ID: mdl-27553854

RESUMEN

Liver cancer has a tendency to develop asymptomatically in patients, so most patients are diagnosed at a later stage. Accumulating evidence implicates that liver tumour-initiating cells (TICs) as being responsible for liver cancer initiation and recurrence. However, the molecular mechanism of liver TIC self-renewal is poorly understood. Here we discover that a long noncoding RNA (lncRNA) termed LncSox4 is highly expressed in hepatocellular carcinoma (HCC) tissues and in liver TICs. We find that LncSox4 is required for liver TIC self-renewal and tumour initiation. LncSox4 interacts with and recruits Stat3 to the Sox4 promoter to initiate the expression of Sox4, which is highly expressed in liver TICs and required for liver TIC self-renewal. The expression level of Sox4 correlates with HCC development, clinical severity and prognosis of patients. Altogether, we find that LncSox4 is highly expressed in liver TICs and is required for their self-renewal.


Asunto(s)
Carcinoma Hepatocelular/metabolismo , Carcinoma Hepatocelular/patología , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/patología , Células Madre Neoplásicas/metabolismo , Células Madre Neoplásicas/patología , ARN Largo no Codificante/genética , ARN Largo no Codificante/metabolismo , Factores de Transcripción SOXC/genética , Factor de Transcripción STAT3/metabolismo , Animales , Carcinoma Hepatocelular/genética , Línea Celular Tumoral , Autorrenovación de las Células/genética , Transformación Celular Neoplásica/genética , Humanos , Neoplasias Hepáticas/genética , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Desnudos , Recurrencia Local de Neoplasia/genética , Recurrencia Local de Neoplasia/metabolismo , Recurrencia Local de Neoplasia/patología , Pronóstico , Regiones Promotoras Genéticas , ARN Neoplásico/genética , ARN Neoplásico/metabolismo , Factores de Transcripción SOXC/metabolismo , Transcriptoma
11.
Int J Endocrinol ; 2016: 8597085, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26884762

RESUMEN

Aims. To examine the association between 4 single nucleotide polymorphisms (SNPs) of peroxisome proliferator-activated receptors δ (PPARδ) polymorphisms and C-reactive protein (CRP) level and additional gene-gene interaction. Methods. Line regression analysis was performed to verify polymorphism association between SNP and CRP levels. Generalized multifactor dimensionality reduction (GMDR) was employed to analyze the interaction. Results. A total of 1028 subjects (538 men, 490 women) were selected. The carriers of the C allele (TC or CC) of rs2016520 were associated with a significant decreased level of CRP, regression coefficients was -0.338, and standard error was 0.104 (p = 0.001). The carriers of the G allele (CG or GG) of rs9794 were also significantly associated with decreased level of CRP, regression coefficients was -0.219, and standard error was 0.114 (p = 0.012). We also found a potential gene-gene interaction between rs2016520 and rs9794. Subjects with rs2016520-TC or CC, rs9794-CG or GG genotypes have lowest CRP level, difference (95% CI) = -0.50 (-0.69 to -0.21) (p < 0.001), compared to subjects with rs2016520-TT and rs9794-CC genotypes. Conclusions. rs2016520 and rs9794 minor allele of PPARδ and combined effect between the two SNP were associated with decreased CRP level.

12.
J Mater Chem B ; 4(4): 626-634, 2016 Jan 28.
Artículo en Inglés | MEDLINE | ID: mdl-32262944

RESUMEN

In this research, we extended a bioinspired and templated synthesis way for SiO2 to carbonaceous materials, with the success in morphology control and inducing chirality at the nano-scale. The biopolymer-analogue polyamine, i.e., polyethyleneimine (PEI) was employed as a catalytic template for SiO2 formation, and the as-formed PEI@SiO2 hybrids, which combine the rigidity of SiO2 and the chemical activity of PEI, were further used as hard-templates and basic catalysts for the deposition of phenolic resin on PEI@SiO2 under mild conditions. Through further carbonization and etching SiO2, SiO2/carbon composites and carbonaceous materials were produced, respectively. After characterization of these products by SEM, TEM, XPS, Raman spectroscopy, FT-IR, and TG-DTA, it was demonstrated that the morphologies were well transmitted in these successive steps. By taking advantage of the diverse modulation ways on the morphologies and structures of initial PEI templates, it is easy to achieve SiO2/carbon and carbonaceous products with different morphologies, including nanofibrils, nanobelts, and nanotubes. Moreover, this process could also fulfill a steady chirality transmission. When PEI complexed with chiral tartaric acid, the resulting chiral complex could function both as a template and chirality source, and finally chiral nanostructured carbonaceous products were obtained.

13.
PeerJ ; 3: e1229, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26417538

RESUMEN

Overcoming drug-resistance is one of the major challenges to control tuberculosis (TB). The up-regulation of efflux pumps is one common mechanism that leads to drug-resistance. Therefore, immunotherapy targeting these efflux pump antigens could be promising strategy to be combined with current chemotherapy. Considering that CD8+ cytotoxic T lymphocytes (CTLs) induced by antigenic peptides (epitopes) could elicit HLA-restricted anti-TB immune response, efflux pumps from classical ABC family (Mycobacterium tuberculosis, Mtb) were chosen as target antigens to identify CTL epitopes. HLA-A2 restricted candidate peptides from Rv2937, Rv2686c and Rv2687c of Mycobacterium tuberculosis were predicted, synthesized and tested. Five peptides could induce IFN-γ release and cytotoxic activity in PBMCs from HLA-A2(+) PPD(+) donors. Results from HLA-A2/K(b) transgenic mice immunization assay suggested that four peptides Rv2937-p168, Rv2937-p266, Rv2686c-p151, and Rv2686c-p181 could induce significant CTL response in vivo. These results suggested that these novel epitopes could be used as immunotherapy candidates to TB drug-resistance.

14.
Angew Chem Int Ed Engl ; 54(40): 11760-4, 2015 Sep 28.
Artículo en Inglés | MEDLINE | ID: mdl-26259671

RESUMEN

Blockade of the protein-protein interaction between the transmembrane protein programmed cell death protein 1 (PD-1) and its ligand PD-L1 has emerged as a promising immunotherapy for treating cancers. Using the technology of mirror-image phage display, we developed the first hydrolysis-resistant D-peptide antagonists to target the PD-1/PD-L1 pathway. The optimized compound (D) PPA-1 could bind PD-L1 at an affinity of 0.51 µM in vitro. A blockade assay at the cellular level and tumor-bearing mice experiments indicated that (D) PPA-1 could also effectively disrupt the PD-1/PD-L1 interaction in vivo. Thus D-peptide antagonists may provide novel low-molecular-weight drug candidates for cancer immunotherapy.

15.
Cancer Immunol Immunother ; 62(11): 1723-32, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24077852

RESUMEN

PIWIL2, a member of PIWI/AGO family, is expressed in germline stem cells and precancerous stem cells, but not in adult somatic cells. PIWIL2 plays an important role in tumor development. It is considered as a cancer­testis antigen (CT80). It has been reported that the spliced fragment of PIWIL2, PL2L60, was widely expressed in cancer cell lines. In this study, HLA-A2-restricted epitopes from PL2L60 were predicted by online tools. To improve the activity of the native epitope, a candidate peptide P281 with potent binding affinity was chosen to investigate the modification strategy. A series of aromatic amino acids were introduced to substitute the first residue of P281. Then, we tested the binding affinity and stability of the peptide analogs and their ability to elicit specific immune responses both in vitro and in vivo. Our results indicated that the cytotoxic T lymphocytes (CTLs) induced by [4-Cl-Phe1]P281 could elicit more potent activities than that of P281 and other analogs. The CTLs induced by this analog could lyze target cells in HLA-A2-restricted and antigen-specific manners. [4-Cl-Phe1]P281 also showed the best resistance against degradation in human serum. In conclusion, the introduction of the unnatural amino acid, 4-Cl-Phe, into the first position could enhance the activity of the native epitope to induce cytotoxic T lymphocytes. It might be a good strategy to modify other promising native epitopes. The novel epitopes identified in this study could be used as novel candidates to the immunotherapy of HLA-A2 positive patients with tumors expressing PL2L60.


Asunto(s)
Proteínas Argonautas/inmunología , Epítopos de Linfocito T/inmunología , Péptidos/inmunología , Linfocitos T Citotóxicos/inmunología , Empalme Alternativo , Secuencia de Aminoácidos , Sustitución de Aminoácidos , Animales , Antígenos de Neoplasias/genética , Antígenos de Neoplasias/inmunología , Antígenos de Neoplasias/metabolismo , Proteínas Argonautas/genética , Proteínas Argonautas/metabolismo , Western Blotting , Línea Celular , Citotoxicidad Inmunológica/inmunología , Epítopos de Linfocito T/genética , Epítopos de Linfocito T/metabolismo , Regulación Neoplásica de la Expresión Génica , Antígeno HLA-A2/inmunología , Células HT29 , Humanos , Interferón gamma/inmunología , Interferón gamma/metabolismo , Células MCF-7 , Ratones , Ratones Transgénicos , Neoplasias/genética , Neoplasias/metabolismo , Neoplasias/patología , Péptidos/genética , Péptidos/metabolismo , Fenilalanina/genética , Fenilalanina/inmunología , Fenilalanina/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Linfocitos T Citotóxicos/metabolismo
16.
J Org Chem ; 77(9): 4414-9, 2012 May 04.
Artículo en Inglés | MEDLINE | ID: mdl-22509788

RESUMEN

A Lewis acid (Ag(I), Ni(II), or Fe(II)) catalyzed, Cu(II)-mediated thiolation reaction between heteroarenes and thiols was achieved with good yield under base-free conditions. DMSO could serve as an effective methylthiolation reagent for the synthesis of heterocyclic methyl thioethers.


Asunto(s)
Cobre/química , Compuestos Heterocíclicos/síntesis química , Ácidos de Lewis/química , Metales/química , Sulfuros/síntesis química , Catálisis , Compuestos Heterocíclicos/química , Estructura Molecular , Sulfuros/química
17.
Microbiol Immunol ; 56(8): 548-53, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22537173

RESUMEN

The identification of novel cytotoxic T lymphocyte (CTL) epitopes is important to analysis of the involvement of CD8(+) T cells in Mycobacterium tuberculosis infection as well as to the development of peptide vaccines. In this study, a novel CTL epitope from region of difference 11 encoded antigen Rv3425 was identified. Epitopes were predicted by the reversal immunology approach. Rv3425-p118 (LIASNVAGV) was identified as having relatively strong binding affinity and stability towards the HLA-A*0201 molecule. Peripheral blood mononuclear cells pulsed by this peptide were able to release interferon-γ in healthy donors (HLA-A*02(+) purified protein derivative(+)). In cytotoxicity assays in vitro and in vivo, Rv3425-p118 induced CTLs to specifically lyse the target cells. Therefore, this epitope could provide a subunit component for designing vaccines against Mycobacterium tuberculosis.


Asunto(s)
Proteínas Bacterianas/inmunología , Epítopos de Linfocito T/inmunología , Mycobacterium tuberculosis/inmunología , Linfocitos T Citotóxicos/inmunología , Animales , Biología Computacional , Pruebas Inmunológicas de Citotoxicidad , Mapeo Epitopo , Antígeno HLA-A2/metabolismo , Humanos , Interferón gamma/metabolismo , Leucocitos Mononucleares/inmunología , Ratones , Ratones Transgénicos , Unión Proteica
18.
Immunol Lett ; 140(1-2): 68-73, 2011 Oct 30.
Artículo en Inglés | MEDLINE | ID: mdl-21756938

RESUMEN

Cytotoxic T lymphocytes (CTLs) play an important role in the immunity of Mycobacterium tuberculosis (Mtb) infection. In the present study, the identification of novel CTL epitopes from efflux pumps, Rv1258c and Rv1410c, was reported. Candidate native peptides and their analogues were predicted with prediction programs. Rv1410c-p510 (TLAPQVEPL) and Rv1410c-p510-1Y9V (YLAPQVEPV) showed potent binding affinity and stability towards HLA-A*0201 molecule. In enzyme-linked immunospot (ELISPOT) assay, the CTLs induced from peripheral blood mononuclear cells (PBMCs) by these peptides could release interferon-γ (IFN-γ) in at least one healthy donor (HLA-A*02(+), PPD(+)). In cytotoxicity assay in vitro and in vivo, the CTLs induced by Rv1410c-p510-1Y9V could specifically lyse peptide-loaded T2 cells. This is the first report to identify CTL epitopes from the efflux pumps of Mtb. The novel epitope identified could serve as candidate to the multivalent peptide vaccine against drug-resistant M. tuberculosis.


Asunto(s)
Epítopos de Linfocito T/metabolismo , Mycobacterium tuberculosis/inmunología , Linfocitos T Citotóxicos/metabolismo , Vacunas contra la Tuberculosis , Tuberculosis/inmunología , Transportadoras de Casetes de Unión a ATP/síntesis química , Transportadoras de Casetes de Unión a ATP/inmunología , Transportadoras de Casetes de Unión a ATP/metabolismo , Proteínas Bacterianas/síntesis química , Proteínas Bacterianas/inmunología , Proteínas Bacterianas/metabolismo , Línea Celular , Simulación por Computador , Citotoxicidad Inmunológica , Ensayo de Immunospot Ligado a Enzimas , Mapeo Epitopo , Epítopos de Linfocito T/inmunología , Antígeno HLA-A2/metabolismo , Humanos , Interferón gamma/metabolismo , Activación de Linfocitos , Proteínas de Transporte de Membrana/síntesis química , Proteínas de Transporte de Membrana/inmunología , Proteínas de Transporte de Membrana/metabolismo , Mycobacterium tuberculosis/patogenicidad , Fragmentos de Péptidos/síntesis química , Fragmentos de Péptidos/inmunología , Fragmentos de Péptidos/metabolismo , Unión Proteica , Linfocitos T Citotóxicos/inmunología , Linfocitos T Citotóxicos/patología , Tuberculosis/prevención & control
19.
Nan Fang Yi Ke Da Xue Xue Bao ; 30(1): 70-5, 2010 Jan.
Artículo en Chino | MEDLINE | ID: mdl-20117988

RESUMEN

OBJECTIVE: To study the effects of L-arginine (L-Arg) on human colon carcinoma cell line LS174 through NO pathway and the mechanism. METHODS: LS174 cells were cultured in the presence of L-Arg at different concentrations for different time. MTT assay was employed to evaluate the cell proliferation, and the cell morphological changes were observed by optical and electron microscopy. The apoptosis of L-Arg-treated cells was observed by the Annexin V/PI staining. The expression levels of VEGF, COX-2, p53, bcl-2 and bax in the cells were determined using Western blotting and immunocytochemical staining. RESULTS: L-Arg promoted the growth of LS174 cells at a low concentration (0.125 mmol/L) and inhibited the cell growth at higher concentrations (0.5, 2, 8, and 32 mmol/L). Under electron microscope, ultrastructual changes in the cytoplasm and nuclei of LS174 cells were observed 48 h after exposure to L-Arg. Some of the cells showed morphological changes characteristic of cell apoptosis such as cell size reduction, condensation and margination of the nuclear chromatin. Low concentration of L-Arg resulted in a cell apoptosis rate of 2.29%, as compared with the rate of 2.84% in the control group; at higher concentrations, L-Arg caused significantly increased cell apoptosis rates to 26.88%, 28.95%, 63.36%, and 84.51%, respectively. In cells treated with a low concentration of L-Arg, the expressions of VEGF and COX-2 were increased as compared with those in the control cells; higher concentrations of L-Arg obviously decreased the expressions of p53 and bcl-2 and increased the expression of bax. CONCLUSION: Low-concentration L-Arg can promote the growth of LS174 cells probably by up-regulating VEGF and COX-2 protein under the influence of NO, the metabolite of L-Arg. The inhibitory effect of high concentrations of L-Arg is probably mediated by inducing cell apoptosis via NO. The mechanism of L-Arg- induced cell apoptosis may be related to the up-regulation of bax protein and the down-regulation of p53 and bcl-2 proteins.


Asunto(s)
Apoptosis/efectos de los fármacos , Arginina/farmacología , Neoplasias del Colon/patología , Óxido Nítrico/metabolismo , Línea Celular Tumoral , Ciclooxigenasa 2/metabolismo , Relación Dosis-Respuesta a Droga , Humanos , Factor A de Crecimiento Endotelial Vascular/metabolismo
20.
Ai Zheng ; 28(7): 679-84, 2009 Jul.
Artículo en Chino | MEDLINE | ID: mdl-19624891

RESUMEN

BACKGROUND AND OBJECTIVE: Protein 4.1, a component of cell membrane skeleton, plays a role in maintaining the shape and mechanical stability of erythrocytes. Recent researches showed that protein 4.1 may be associated with the development of tumors. This study was to investigate the expression and significance of membrane skeleton protein 4.1 family members (4.1B, 4.1R, 4.1N and 4.1G) in human non-small cell lung cancer (NSCLC). METHODS: The expression of proteins 4.1B, 4.1R, 4.1N and 4.1G in 147 specimens of NSCLC was detected by EnVision plus immunohistochemistry. The correlations of 4.1B, 4.1R, 4.1N and 4.1G expression to clinicopathologic features of NSCLC were analyzed by Wilcoxon rank sum test and Spearman rank correlation analysis. RESULTS: The protein levels of 4.1B, 4.1R and 4.1N were significantly lower in lung squamous cell carcinoma tissues than in adjacent normal tissues (P<0.01). The protein levels of 4.1B, 4.1R, 4.1N and 4.1G were significantly lower in lung adenocarcinoma tissues than in adjacent normal tissues (P<0.05). The protein levels of 4.1B and 4.1G were significantly lower in lung squamous cell carcinoma tissues than in lung adenocarcinoma tissues (P<0.05). Protein 4.1G expression in squamous cell carcinoma was positively correlated to tumor cell differentiation (rs=0.386,P<0.01). In adenocarcinoma, the expression of proteins 4.1B, 4.1N and 4.1G were positively correlated to tumor cell differentiation (rs=0.276, P<0.05; rs=0.248,P<0.05; rs=0.268, P <0.05). The expression of protein 4.1s in squamous cell carcinoma and adenocarcinoma were not related to lymph node metastasis, tumor size, patients'age and sex (P>0.05). CONCLUSIONS: Protein 4.1s are weakly expressed in NSCLC tissues than in adjacent normal tissues. The expression of proteins 4.1B, 4.1N and 4.1G are related to tumor cell differentiation.


Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/metabolismo , Diferenciación Celular , Proteínas del Citoesqueleto/metabolismo , Neoplasias Pulmonares/metabolismo , Proteínas de la Membrana/metabolismo , Adenocarcinoma/metabolismo , Adenocarcinoma/patología , Adulto , Anciano , Carcinoma de Pulmón de Células no Pequeñas/patología , Carcinoma de Células Escamosas/metabolismo , Carcinoma de Células Escamosas/patología , Femenino , Humanos , Pulmón/metabolismo , Neoplasias Pulmonares/patología , Metástasis Linfática , Masculino , Persona de Mediana Edad , Carga Tumoral
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA